The remediation of infectious diseases is an ongoing concern in healthcare structures due to the continued loss of efficacies of existing schedules and, in particular, the poignant threat of multidrug resistance. In the search for new therapies plants have emerged as an attractive option owing to their vast chemical resources. Allied to this feature is the widespread use of plants in traditional approaches towards infectious diseases. As far as the family Amaryllidaceae is concerned, around fifty of its members are identifiable with such distinctive functions in traditional medicine. This review examines the in vitro antibacterial activities of its plant extracts and sheds light on instances where these are corroborative of the traditional usage.
The discovery of penicillin by Alexander Fleming in 1948 ushered in the golden age of antibiotic drug discovery which was to last until the 1980s [1a] . Peaking in the 1950s this period oversaw the identification of no less than twenty-eight different classes of antibiotics some of which, such as erythromycin, vancomycin and metronidazole, proved to be lifesaving drugs [1a] . Many of the drugs which debuted during this prolific time for discovery were derived from bacterial sources, mainly from the Actinobacteria [1a] . Regretably, this phenomenon became increasingly untenable as scientific barriers to drug discovery, regulatory challenges and diminishing returns on investment pressured major drug companies to scale back or abandon altogether their antibiotic research operations [1b,c] . So severe have been the repercussions that nearly all antibiotics brought to market over the past 30 years have been variations on existing drugs [1a] .
The situation has been compounded by the fact that most drugs have a limited lifespan, their efficacy declines with time and in the case of antibiotics they can be severely compromised via multidrug resistance [2a] . Forecasts on the topic are bleak with the World Health Organization (WHO) in particular cautioning against a "post-antibiotic" era in which common infections and minor injuries once again become lethal [2b,c] . Several suggestions have been made on how to possibly circumvent such a scenario in future including; (i) advocating alternative treatment strategies to minimize conventional antibiotic usage and, (ii) broadening the basis for antibiotic discovery via the design of new chemical matter [2a-c] . These two factors are impingent directly on the traditional medicine (TM) sector and its relevance in the treatment of infectious diseases [3a-c] . Plants have long served man well in his quest for good health and well-being [3a-c,4] . The use of plants to treat microbial infections is extensive [3a-c] . The Napralert database, for example, has records of over 6000 species which have published experimental data pertaining to antimicrobial activity [3c] . This information becomes even more poignant considering that the majority of these species (>4000) possess verifiable ethnomedical data supporting their claim in the treatment of infectious diseases [3c] .
The bulbous plant family Amaryllidaceae has a significant numerical presence in tropical and subtropical regions [5] . Furthermore, its members are richly represented in the medicinal traditions of indigenous cultures around the world [6a-j] . For example, in South Africa the Amaryllidaceae is one of the most popular bulbous plant families exploited in the TM of the indigenous San, Sotho, Xhosa and Zulu peoples [6a,b,k] . This is significant as the Amaryllidaceae is most populous in this region which has also in recent years emerged as a hotspot for ethnopharmacological investigations [6c,d,g-j] . Information gathered from the ethnic usage of several of its representatives has guided breakthrough discoveries in the cancer and motor neuron disease arenas, of which much has been written in recent times [7a,b] . However, the Amaryllidaceae is also widely used in the traditional remediation of infectious diseases with as many as fortyeight of its species having documentary evidence for such functions in ethnic medicine [6h] . This review seeks to identify and highlight the use of these plants for infections arising out of bacterial pathogenesis. Furthermore, it is intended that the activities exposed for the various extracts and isolates against a wide range of bacteria would in part substantiate the traditional usage of these plants.
Spencer and co-workers had initiated microbial studies of the Amaryllidaceae in as early as 1947 when extracts of several species were examined for effects against Plasmodium gallinaceum [8] . This was followed exactly two decades later by Ceriotti (1967) who uncovered the antibacterial activity of an alkaloid isolate of Narcissus bulbs [9] . However, the first detailed study of extracts of Amaryllidaceae plants had to wait until 1979 when Ieven et al. studied the five species Clivia cyrtanthifolia, Clivia miniata, Hymenocallis littoralis, Narcissus pseudonarcissus and Narcissus tazetta for antibacterial effects [10] . After this there was a sustained period of dormancy into the late 1990s following which interest in the Amaryllidaceae as a source of antimicrobial agents has been rejuvenated.
properties [6h,j,k,11a-d] . Inhibition zone diameters measured by Shale et al. (1999) against seven common pathogens were not particularly striking, ranging from 0 to 0.3 mm (Table 1) for leaf and root extracts applied at 100 mg/mL [11b] . However, Cheesman et al. (2012) showed via the microdilution method that ethanolic bulb extracts exhibited significant activities against E. coli, K. pneumoniae and S. aureus (MIC 0.13 mg/mL, respectively) as well as B. subtilis (MIC 0.25 mg/mL) [11d] . Brunsvigia grandiflora is the only member of the genus Brunsvigia known in South African TM for the treatment of infection-related conditions such as diarrhoea and respiratory tract infections [6h,12a-c] . However, both organic and aqueous bulb extracts of the plant examined against K. pneumoniae and S. aureus were shown to have mild effects (MICs 3.13-12.5 mg/mL) when compared to the corresponding antibiotic standard neomycin (MIC 0.0975 mg/mL) [12b] . As referred to above, Ieven et al. (1979) had investigated the two Clivia species C. cyrtanthifolia and C. miniata in the hole-plate dilution assay, showing that both exhibited positive effects against S. aureus at concentrations ranging from 50-500 g/mL [10] . Furthermore, only C. cyrtanthifolia was active against P. aeruginosa, whilst both species at similar concentrations had no observable effects on E. coli and P. vulgaris [10] . In addition, organic extracts (ethyl acetate and chloroform) of whole plants of C. miniata were inactive against Listeria monocytogenes which is responsible for listeriosis in some cases of food poisoning [13] .
The genus Crinum recorded the most number of species (nineteen) that are used in TM for infections, of which nine have been evaluated in various bacterial assays (Table 1) The Turkish medicinal plants Galanthus elwesii, Leucojum aestivum and Narcissus tazetta were tested against the pathogen Pseudomonas solanacearum and shown to be inactive [16a] . Furthermore, ethanol bulb extracts of these plants were exposed to E. coli and S. aureus cultures via the broth dilution method, wherein only N. tazetta demonstrated a measurable level of activity (MIC 2.05 mg/mL) [16b] . Eustephia coccinea was amongst several Peruvian medicinal plants used for diverse infections and shown to exhibit weak activity (MIC 32 mg/mL) in the screen against S. aureus [16c,d] . Gethyllis species were in general inactive and of the three representatives examined only bulb DCM extracts of Gethyllis ciliaris exhibited some activity, albeit with a negligible inhibition zone diameter of 0.21 mm in E. coli cultures at the relatively high dose of 100 mg/mL [15a] . However, leaf and root extracts of G. ciliaris were noted for their bacteriostatic effects on the B. subtilis and E. coli pathogens [15a] . In addition to the two Clivia species mentioned above, Ieven et al. (1979) also examined Hymenocallis littoralis, Narcissus pseudonarcissus and N. tazetta for effects against E. coli, P. vulgaris, P. aeruginosa and S. aureus. In the event whole plant water extracts of all three plants were active against the Gram-positive S. aureus in the dose range 50-500 g/mL, whilst only H. littoralis had a positive response to P. aeruginosa [10] . Apart from this, H. littoralis leaf extracts were active (MIC 6.25 mg/mL) in E. coli cultures in which they effected heavy cell wall rupture as observed under SEM [16e] . N. tazetta is known in Turkey for its various medicinal attributes, particularly when it comes to treating wounds and infections [6e,6h] . Of the remaining three Narcissus species N. bulbocodium, N. jonquilla and N. poeticus, only the latter was active against S. aureus (MIC 2.05 mg/mL) when assayed against this pathogen as well as E. coli [16b] . Although Lycoris chinensis is a Chinese medicinal plant reputed for its wound healing properties, it was inactive against as many as seven different bacterial pathogens [16f]. However, it displayed moderate activity in Bacillus thuringiensis cultures where an inhibition zone diameter of 9.21 mm (at 300 mg/mL) was measured, roughly half that of the standard gentamycin (17.24 mm at 1 g/disc) [16f]. On the other hand, the Korean medicinal plant Lycoris radiata was active in assays involving E. coli, S. aureus and Helicobacter pylori in which inhibition zone diameters ranged from 9-13 mm when bulb extracts were applied at 3.3 mg/mL [16g].
Pancratium maritimum is not known for its use to treat infections, but was nonetheless subjected to screening procedures against a wide array of bacterial pathogens [16a,17a,b] By the same token, leaf and bulb extracts of S. puniceus were exposed to six different bacterial pathogens and shown to be active in most cases with MICs ranging from 1.56 to >16 mg/mL [15c,17e]. The latter of these two works is significant since Mixed responses were observed following exposure of aqueous and organic extracts of bulbs and aerial parts of Sternbergia lutea and Sternbergia sicula to seven different bacterial pathogens [18a] , neither of which have recorded usage in the traditional therapy of infectious diseases. Strikingly, of the sixteen extracts screened (eight per plant) none were active against Enterobacter cloacae or Enterococcus faecalis (Table 1 ) [18a] . Similarly, the various extracts of both plants were mostly inactive towards P. aeruginosa and Stapylococcus epidermis [18a] . Overall, the best activities were detected in E. coli, S. typhimurium and S. aureus cultures ranging from 8-11 mm for diameters of the inhibition zones [18a] . Tuberculosis is a widespread infectious disease caused by various strains of Mycobacterium, but mainly by Mycobacterium tuberculosis [19a,b] . This debilitating disease is a major health risk and ranks alongside AIDS as a leading cause of death worldwide [19c] . TB is a serious concern for Africa, especially sub-Saharan Africa which is now recognized as the epicentre of the disease [19c] . This scenario has been exacerbated by ailing healthcare structures, which often hamper access to treatment regimens, as well as the proliferation of multidrug-resistant TB [19c] . In spite of this and given the rich fabric of TM, medicinal plants continue to serve as the first-line of defence against TB in many of these regions [19a,b] . These practices have also been bolstered by the discovery of antitubercular activities for several classes of natural products identified in these plants, such as terpenoids, flavonoids, alkaloids, coumarins, quinones, lignans, stilbenes and saponins [19a,b] .
The use of Amaryllidaceae plants in traditional remedies of TB is restricted to the African continent where the two prominent regions are Nigeria and South Africa [6a,b,6h,12b,c,17e,19d-f] 19e] . In the event, none of the plant extracts tested at 0.02 mg/mL exhibited growth inhibitory effects on the bacterium [19e] . In particular, the results for the Amaryllid C. glaucum were disappointing as the number of colonies observed for both aqueous and ethanol extracts were >100 cfu/mL (Table 1) compared to the isoniazid-treated cultures wherein no growth was observed [19e] . By contrast, the positive findings of Akintola et al. (2013) 19i] . Since Mycobacterium species are known to induce expression and induction of matrix metalloproteinase-9 which is involved in COX-2 reliant signaling events [19j] , it has been suggested that the development of selective COX-2 inhibitors could be significant in the therapy of inflammatory pulmonary TB [12c].
Leprosy is a chronic infectious disease which affects the skin, peripheral nerves, upper respiratory tract and eyes has been prevalent in society for thousands of years [20a] . It is caused by the bacilli Mycobacterium leprae and Mycobacterium lepromatosis [20a] . Although now widely eradicated due to intensive treatment regimens (such as multidrug therapy) which are provided cost-free by the WHO via national healthcare bodies, leprosy is still existent in developing countries in Africa and Asia [20a] . In particular, there is a high incidence of the disease on the Indian subcontinent which accounts for the majority of new cases diagnosed annually [20a] . Plants have long served as a conventional measure in the treatment of this debilitating condition, especially in rural communities across Africa and Asia [20b, c] . In relation to the management of this mycobacterial disease in TM with Amaryllidaceae plants, Crinum giganteum, Crinum scabrum and Cyrtanthus obliquus have been indicated for this purpose, the first two in the DRC and the latter in South Africa [6a,d] . Also noteworthy is the use of Cyrtanthus obliquus in South Africa for both mycobacterial diseases i.e. TB and leprosy [6a] .
In summary, plants of the Amaryllidaceae as outlined herein are relevant in the TM of infectious diseases. This survey accounts for thirty-nine species from seventeen genera which have been examined against a total of twenty-nine different Gram-positive and Gram-negative bacterial pathogens. Out of these species, twentyone (53.9%) are documented for infection-related conditions, wherein Crinum, Cyrtanthus and Gethyllis were the genera most studied. Ongoing efforts should focus on the remaining species which are known from TM, as well as the identification of the active constituents.
